Fundraising Fox

Chimerix NASDAQ: CMRX www.chimerix.com

Founded 2003 · 3,654 employees on LinkedIn · 6 known investors

Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.

BiotechHealthtechMedical Devices

Investors · 6

Aisling CapitalNew York
Alta PartnersJackson · $1M – $12M
Asset Management CompanyMenlo Park · $500K – $2M
Canaan PartnersStamford · $500K – $20M
Frazier Life SciencesPalo Alto
Sanderling VenturesSan Mateo · $50K – $1M

Frequently asked questions

What does Chimerix NASDAQ: CMRX www.chimerix.com do?
Chimerix is a biopharmaceutical company developing therapies for rare diseases and cancers, with a focus on advancing treatments through biomarker-driven approaches and precision medicine.
Who are Chimerix NASDAQ: CMRX www.chimerix.com's investors?
Chimerix NASDAQ: CMRX www.chimerix.com's investors include Aisling Capital, Alta Partners, Asset Management Company, Canaan Partners, Frazier Life Sciences, Sanderling Ventures.